Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

13 Canadian Crypto ETFs (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

How Could Trump's US Election Win Affect the Gold Price?

Top 4 Largest Lithium Reserves by Country (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Trending Press Releases

Osisko Metals Announces Significant Increase in Mineral Resources at Gaspé Copper

Bitcoin Well Provides Update to the Bitcoin Super Company Vision and Bitcoin Reserve Fund

OSISKO METALS EXPANDS LEADERSHIP TEAM AND ANNOUNCES C$100 MILLION BOUGHT DEAL FINANCING

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50 g/t Silver, 21.97% Zinc, 7.03% Lead, 0.42% Copper at Its Red Mountain Project, Alaska

McDermitt PFS Demonstrates Multi-Decade Competitive Source of US Lithium Carbonate

Results of Updated Scoping Study for Nueva Sabana Mine, Cuba

More Press Releases
Trending Companies

Purpose Bitcoin ETF

BTCC:CA

Silver47 Exploration

AGA:CC

Syntheia

SYAI:CC

Black Swan Graphene

SWAN:CC
More Companies
Trending Reports

2024 Lithium Market Outlook

2024 Gold Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 AI Market Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Caribou Biosciences Inc.

NASDAQ:CRBU
Press Releases

Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology Annual Meeting

Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences

Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

Interactive Chart

×